Pharmacological inhibition of NOS activity or genetic deletion of eNOS induces PE-like characteristics, including hypertension, proteinuria, impaired spiral artery remodeling, and fetal growth restriction, in murine models49–52. This evidence concerns the gene NOS3 and hypertensive disorder.